Topamax Linked to Cleft Palate, Other Birth Defects

In March of 2011, the FDA graded Topamax as a Category D medication, a drug that shows positive evidence of human fetal risk.

When taken during pregnancy, Topamax, originally prescribed to treat migraine headaches and epilepsy, has been shown to increase the risk of birth defects and oral deformities in the developing fetus.

Specific birth defects that have been linked to Topamax are:  cleft palate, cleft lip, fetal and skeletal malformations and hypospadias (malformation of the urethra in boys).

A cleft palate or lip occurs when the mouth fails to fully form, causing a split or gap in the roof of the mouth.  These deformities may cause developmental issues and can lead to severe ear infections and problems with eating and talking.

Topamax has also been prescribed “off label” for conditions such as:  bipolar disorder, post traumatic stress disorder, infantile spasms, bulimia, obsessive compulsive disorder, obesity and neuropathy.

If you took Topamax during the first trimester of your pregnancy and your child was born with a cleft palate, cleft lip or other oral birth defect, you may be eligible for compensation.  Contact one of our injury attorneys today for answers.